Guardian Capital LP Merck & Co., Inc. Transaction History

Guardian Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $981,279 - $1.07 Million	-12,898 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $5.03 Million - $5.87 Million	-71,981 Reduced 84.8%	12,898 $1.08 Million
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $1.93 Million - $2.2 Million	27,752 Added 48.58%	84,879 $7.06 Million
Q4 2018 Feb 13, 2019	BUY	$65.24 - $75.71 $3.73 Million - $4.33 Million	57,127 New	57,127 $4.37 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $4.43 Million - $5.15 Million	-86,907 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $39,953 - $47,709	774 Added 0.9%	86,907 $4.89 Million
Q3 2017 Nov 15, 2017	SELL	$58.67 - $63.13 $8,741 - $9,406	-149 Reduced 0.17%	86,133 $5.52 Million
Q2 2017 Aug 14, 2017	BUY	N/A	86,282	86,282 $5.53 Million

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Capital LP with notifications on news.